Our previous study demonstrated that MUS81 was overexpressed and it promoted tumor metastasis by regulating the expression of the epithelial–mesenchymal transition (EMT) marker ZEB1 in gastric cancer [26]; however, its therapeutic value as a predictive target needs to be further studied in gastric cancer. Here, ZEB1 is linked to gastric cancer.